IndraLab

Statements


FADH2 activates UCHL1. 1 / 1
| 1

reach
"However, as documented in Table 3, research laid the foundation for U.S. Food and Drug Administration (FDA) accelerated approval of measures of UCH-L1 and GFAP for acute diagnosis of TBI not associated with CT abnormalities versus moderate TBI associated with CT abnormalities."